| Balance Sheet for Vertex Pharmaceuticals Inc. (VRTX) | | | | After Hours: $ 23.69 | -1.75 (-6.88%) | Volume: 2.9 k | 4:15 PM EDT Oct 10, 2008 | | | | | | | Assets | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Cash and Equivalents | 355,663 | 213,171 | 78,045 | 55,006 | 98,159 | | Marketable Securities | 105,208 | 491,455 | 283,112 | 337,314 | 485,005 | | Receivables | 31,320 | 62,923 | 20,595 | 11,891 | 7,324 | | Inventories | - | - | - | - | - | | Other Current Assets | - | - | - | - | - | | Total Current Assets | 496,851 | 771,406 | 385,055 | 406,712 | 593,806 | | | Gross Fixed Assets | 239,888 | 213,520 | 202,359 | 191,019 | 186,534 | | Accumulated Depreciation | (173,379) | (151,985) | (147,826) | (126,794) | (106,451) | | Net Fixed Assets | 66,509 | 61,535 | 54,533 | 64,225 | 80,083 | | Intangibles | - | - | - | - | - | | Other Non-Current Assets | 38,117 | 88,638 | 109,410 | 74,516 | 50,522 | | Total Non-Current Assets | 104,626 | 150,173 | 163,943 | 138,741 | 130,605 | | Total Assets | 601,477 | 921,579 | 548,998 | 545,453 | 724,411 | | | Liabilities | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Accounts Payable | 32,750 | 15,368 | 6,210 | 6,660 | 12,306 | | Short Term Debt | 19,997 | 2,008 | - | - | 4,660 | | Other Current Liabilities | 27,151 | 4,635 | 2,988 | 4,688 | 14,000 | | Total Current Liabilities | 199,279 | 251,014 | 100,243 | 153,745 | 139,067 | | | Long Term Debt | - | 19,997 | 180,097 | 334,997 | 315,000 | | Deferred Income Tax | - | - | - | - | - | | Other Non-Current Liabilities | 130,903 | 144,633 | 29,482 | 21,270 | 51,771 | | Minority Interest | - | - | - | - | - | | Total Non-Current Liabilities | 130,903 | 164,630 | 209,579 | 356,267 | 392,499 | | Total Liabilities | 330,182 | 415,644 | 309,822 | 510,012 | 531,566 | | | Preferred Stock Equity | - | - | - | - | - | | Common Stock Equity | 271,295 | 505,935 | 239,176 | 35,441 | 192,845 | | Total Equity | 271,295 | 505,935 | 239,176 | 35,441 | 192,845 | | Total Liabilities & Stock Equity | 601,477 | 921,579 | 548,998 | 545,453 | 724,411 | | | |